Carregant...
A Patient-Derived Xenograft Model of Glioblastoma
Glioblastoma (GBM) remains the most common malignant primary brain tumor in adults with a median survival of less than ~15 months. Further understanding and therapeutic development rely on the use of clinically relevant models of GBM. Here, we present our patient-derived in vitro and in vivo models...
Guardat en:
| Publicat a: | STAR Protoc |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7757408/ https://ncbi.nlm.nih.gov/pubmed/33377073 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.xpro.2020.100179 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|